Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in – but the highly anticipated doesn't seem to have lived up to investor expectations. MariTide (maridebart ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments ...